Cargando…
Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis
BACKGROUND: The new coronavirus-related pneumonia is causing a global pandemic without specific antiviral drug. Ribavirin has activity against extensive RNA and DNA viruses. We plan to systematically review the use of ribavirin in patients with coronavirus-related pneumonia and meta-analyze the data...
Autores principales: | Wang, Yinhua, Li, Wen, Jiang, Zhiming, Xi, Xiuming, Zhu, Yibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505389/ https://www.ncbi.nlm.nih.gov/pubmed/32957417 http://dx.doi.org/10.1097/MD.0000000000022379 |
Ejemplares similares
-
Assessment of Chinese medicine for coronavirus-related pneumonia: A protocol for systematic review and meta-analysis
por: Zhu, Yibing, et al.
Publicado: (2020) -
Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
por: Li, Runmin, et al.
Publicado: (2020) -
Effects and safety of tanreqing injection on viral pneumonia: A protocol for systematic review and meta-analysis
por: Liu, Hui, et al.
Publicado: (2020) -
A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019
por: Wang, Xuemei, et al.
Publicado: (2020) -
The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020)